Actively Recruiting
Tailored One Anastomosis Gastric Bypass
Led by Tel-Aviv Sourasky Medical Center · Updated on 2025-07-24
500
Participants Needed
1
Research Sites
209 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
One Anastomosis Gastric Bypass (OAGB) is the most common metabolic and bariatric surgery (MBS) in Israel, recognized for its effectiveness in achieving sustainable weight loss and mitigating obesity-related diseases. The metabolic outcomes of OAGB are significantly influenced by the length of the biliopancreatic limb (BPL). The objective of this study is to determine whether tailoring the BPL length to the total small bowel length (TSBL) results in more effective weight loss compared to patients undergoing OAGB with a fixed BPL of 180 cm. Efficacy and safety of this approach will also be evaluated, ensuring it does not lead to long-term morbidity or negatively impact patients' quality of life.
CONDITIONS
Official Title
Tailored One Anastomosis Gastric Bypass
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (18 years or older) scheduled for One Anastomosis Gastric Bypass surgery
You will not qualify if you...
- Patients younger than 18 years
- Pregnant women
- Individuals lacking decision-making capacity
- Previous bariatric surgery
- Short small bowel length less than 450 cm
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Actively Recruiting
Research Team
A
Adam Abu-Abeid, M.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here